Drug Database
Back to search

Netherlands· NL-ce2d3d54f113

Lanvis 40 mg tabletten

A tioguanine product containing tioguanine, registered in Netherlands by Aspen Pharma Trading Limited. The same ATC class is registered in 13 of our 19 countries.

ATC L01BB03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLanvis 40 mg tablettenATCL01BB03REGISTER NO.NL-ce2d3d54f113PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tioguanineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tioguanine is registered in 13 of 19 countries.

Countries holding a registration under ATC L01BB03 (tioguanine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search tioguanine products by name

Tioguanine · ATC L01BB03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TIOGUANINE
Manufacturer
Aspen Pharma Trading Limited
Country
Netherlands (NL)
ATC code
L01BB03
ATC class
Tioguanine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    07070

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

434 interactions on record for tioguanine.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tioguanine against other medicinesHow interaction checks work

Tioguanine · interactions on record

434 records

  • 33 severe
  • 377 moderate
  • 13 minor
  • 11 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • CladribineL01BB04severe
  • ClotrimazoleA01AB18moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tioguanine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tioguanine products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Thioguanin Aspen
  • Belgium · Lanvis
  • Czechia · Lanvis
  • Germany · Thioguanin Aspen
  • Estonia · Lanvis
  • Spain · Lanvis
  • France · Lanvis
  • Ireland · Lanvis
  • Italy · Tioguanina
  • Lithuania · Lanvis
  • Poland · Lanvis
  • Romania · Lanvis
  • Sweden · Lanvis
  • Slovakia · Lanvis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/64fa01ab-df79-4773-a24c-e1d49b7074cc
GET /v1/drugs/64fa01ab-df79-4773-a24c-e1d49b7074cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h07070_smpc.pdf",
  "strength": null,
  "atc_label": "Tioguanine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg07070",
  "excipients": [
    "AARDAPPELZETMEEL",
    "ARABISCHE GOM (E 414)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "STEARINEZUUR (E 570)"
  ],
  "substances": [
    "TIOGUANINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h07070.pdf",
  "authorised_at": "1975/08/15",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "07070",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tioguanine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console